These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
643 related articles for article (PubMed ID: 23594368)
1. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Deutsch VR; Tomer A Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368 [TBL] [Abstract][Full Text] [Related]
2. Megakaryocyte development and platelet production. Deutsch VR; Tomer A Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888 [TBL] [Abstract][Full Text] [Related]
3. [Megakaryocyte development and platelet production in normal and disease states]. Deutsch V; Katz BZ; Tomer A Harefuah; 2010 May; 149(5):291-7, 336. PubMed ID: 20929068 [TBL] [Abstract][Full Text] [Related]
4. [Megakaryopoiesis: regulation of platelet production by thrombopoietin]. Vainchenker W; Besancenot R; Favale F Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369 [TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin from beginning to end. Hitchcock IS; Kaushansky K Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199 [TBL] [Abstract][Full Text] [Related]
6. Milestones in understanding platelet production: a historical overview. Kuter DJ Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208 [TBL] [Abstract][Full Text] [Related]
7. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis. Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624 [TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura. Gernsheimer TB Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086 [TBL] [Abstract][Full Text] [Related]
10. Compared effects of Mpl ligand and other cytokines on human MK differentiation. Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176 [TBL] [Abstract][Full Text] [Related]
11. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture. Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520 [TBL] [Abstract][Full Text] [Related]
12. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets. Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264 [TBL] [Abstract][Full Text] [Related]
13. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro. Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M Platelets; 2011; 22(3):196-203. PubMed ID: 21231855 [TBL] [Abstract][Full Text] [Related]
14. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Avecilla ST; Hattori K; Heissig B; Tejada R; Liao F; Shido K; Jin DK; Dias S; Zhang F; Hartman TE; Hackett NR; Crystal RG; Witte L; Hicklin DJ; Bohlen P; Eaton D; Lyden D; de Sauvage F; Rafii S Nat Med; 2004 Jan; 10(1):64-71. PubMed ID: 14702636 [TBL] [Abstract][Full Text] [Related]
15. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413 [TBL] [Abstract][Full Text] [Related]
16. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin. Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635 [TBL] [Abstract][Full Text] [Related]
17. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793 [TBL] [Abstract][Full Text] [Related]
18. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice. Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120 [TBL] [Abstract][Full Text] [Related]
20. What is the potential for thrombopoietic agents in acute leukemia? Kuter DJ Best Pract Res Clin Haematol; 2011 Dec; 24(4):553-8. PubMed ID: 22127320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]